Early results from an Ebola trial using Avigan (favipiravir), the experimental drug, showed that it was somewhat effective at saving lives if given early in the illness, but not later, as reported on Monday. The antiviral treatment is being developed by the Japanese company Toyama Chemical, and has been shown safe and effective against some other viruses including influenza, West Nile and yellow fever. An ongoing clinical trial in Guinea is testing the ...
http://ift.tt/1zCAwb6
http://ift.tt/1BWgEAm
No comments:
Post a Comment